PKM and hepatocellular carcinoma: PKM2-IN-1 reduced glucose uptake and lactate production in esophageal and hepatocellular carcinoma cells38,39 and 3PO inhibited growth of lung cancer, breast cancer and promyelocytic leukemia cells14.